Intensification of Metformin treatment in diabetic patients with Insulin versus Sulfonylureas

Main Article Content

Mahdi Mohammadian Hamid Salehiniya Salman Khazaei Abdollah Mohammadian-Hafshejani

Abstract

Diabetes is one of the most common chronic diseases, so that the number of diabetics was 221 million worldwide in 2010. Diabetes has no decisive cure and can lead to fatal complications. This disease is the most common cause of amputation, blindness and chronic renal failure and one of the most important risk factors for coronary heart diseases (Masoudi et al., 2004). The global incidence of diabetes is increasing due to the increased obesity and decreased physical activity (Bidarpour et al., 2003). Non-insulin dependent or type 2 diabetes is now an epidemic in the United States; and it had the prevalence of 7 percent in adults over 30 years in 2000 (Hillier and Pedula, 2001).

 

References

Bidarpour, F., HOLAKOUEI, N.K., Rahimi, A., and ESMAEILNASAB, N. (2003). A survey of risk factors for type 2 diabetes in patients of Kurdistan Diabetic Center in 2001. Scientific Journal of Kurdistan university of medical sciences, 20-35.
Fenton, J.J., Von Korff, M., Lin, E.H., Ciechanowski, P., and Young, B.A. (2006). Quality of preventive care for diabetes: effects of visit frequency and competing demands. The Annals of Family Medicine 4, 32-39.
Harrison, L.B., Adams-Huet, B., Raskin, P., and Lingvay, I. (2012). beta-cell function preservation after 3.5 years of intensive diabetes therapy. Diabetes Care 35, 1406-1412.
Hillier, T.A., and Pedula, K.L. (2001). Characteristics of an adult population with newly diagnosed type 2 diabetes. Diabetes care 24, 1522-1527.
Holden, S.E., Poole, C.D., Morgan, C.L., and Currie, C.J. (2011). Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin. BMJ open 1, e000258.
Inzucchi, S.E., Bergenstal, R.M., Buse, J.B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A.L., Tsapas, A., Wender, R., and Matthews, D.R. (2012). Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35, 1364-1379.
Masoudi, A.N., Ghofranipour, F., Ahmadi, F., Babaei, G.H., and Rajab, A. (2004). Evaluation of effectiveness of community based interventions on controlling diabetes mellitus in Tehran, 1382. Iranian Journal of Diabetes And Lipid Disorders, 85-93.
Pringle, M., Stewart-Evans, C., Coupland, C., Williams, I., Allison, S., and Sterland, J. (1993). Influences on control in diabetes mellitus: patient, doctor, practice, or delivery of care? Bmj 306, 630-634.
Roumie, C.L., Greevy, R.A., Grijalva, C.G., Hung, A.M., Liu, X., Murff, H.J., Elasy, T.A., and Griffin, M.R. (2014). Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes. Jama 311, 2288-2296.

Downloads

Download data is not yet available.

Article Details

How to Cite
MOHAMMADIAN, Mahdi et al. Intensification of Metformin treatment in diabetic patients with Insulin versus Sulfonylureas. Biomedical Research and Therapy, [S.l.], v. 4, n. 06, p. 1341-1343, june 2017. ISSN 2198-4093. Available at: <http://www.bmrat.org/index.php/BMRAT/article/view/177>. Date accessed: 23 oct. 2017. doi: https://doi.org/10.15419/bmrat.v4i06.177.
Section
Letter to Editor

Most read articles by the same author(s)